FDA inspection
Nesher Pharmaceuticals (USA) LLC: FDA inspection ending Jul 18, 2018
FDA inspection 1059731 · Official Action Indicated (OAI) · Bridgeton, MO
Key facts
| Inspection ID | 1059731 |
|---|---|
| Firm | Nesher Pharmaceuticals (USA) LLC |
| FEI number | 1922352 |
| Address | 13910 Saint Charles Rock Rd |
| City | Bridgeton |
| State | MO |
| ZIP | 63044-3826 |
| Fiscal year | 2018 |
| Inspection end date | Jul 18, 2018 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data